Bharat Biotech submits additional data to WHO

Hyderabad-based Bharat Biotech has submitted “additional data” to the Technical Advisory Group (TAG) of the World Health Organization (WHO), which is needed for it to finalise the assessment required for granting the much-awaited Emergency Use Listing (EUL) to Covaxin.

According to sources, TAG had sought “gender wise” immunogenicity data on adults aged 60 plus from the company.

“There is a particular format that the company had to follow. Separate data for both male and female was needed from the company,” according to the people cited.

The data was submitted on Friday, they said.

In its meeting on October 26, the TAG had sought “additional clarification” from Bharat Biotech to conduct a final risk-benefit assessment for global use of Covaxin.

WHO had said that TAG will reconvene for the final assessment on Wednesday, if Bharat Biotech is able to send the required data.

“The TAG expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, 3 November,” WHO told ET in an email response.

WHO’s TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergency use under the EUL procedure.

WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and Sinopharm for emergency use.

“Covaxin has not taken longer than all the other vaccines that have been through EUL,” WHO told ET.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 96 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 66 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down